Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study

V. Poletti (Forlì, Italy), C. Vancheri (Catania, Italy), C. Albera (Torino, Italy), S. Harari (Milano, Italy), A. Pesci (Monza, Italy), P. Rottoli (Siena, Italy), B. Campolo (Milano, Italy), D. Lorenzo (Milano, Italy), R. Barbara On Behalf Of Fibronet Study Group (Modena, Italy)

Source: International Congress 2019 – Interstitial lung disease registries
Session: Interstitial lung disease registries
Session type: Thematic Poster
Number: 4708
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Poletti (Forlì, Italy), C. Vancheri (Catania, Italy), C. Albera (Torino, Italy), S. Harari (Milano, Italy), A. Pesci (Monza, Italy), P. Rottoli (Siena, Italy), B. Campolo (Milano, Italy), D. Lorenzo (Milano, Italy), R. Barbara On Behalf Of Fibronet Study Group (Modena, Italy). Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study. 4708

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - IPF symptoms’ course during a 3-month observation: FIBRONET observational study’s preliminary results.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017


COVID-19 pneumonia and clinical follow-up: results of a prospective cohort
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021


Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study
Source: Virtual Congress 2021 – Imaging in COVID-19
Year: 2021


Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study).
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Adequacy of treatment in COPD patients referred to the emergency room for disease exacerbation: an Italian multicentre observational study (the COXER study)
Source: Annual Congress 2008 - Management of COPD
Year: 2008


Treatment patterns in stable COPD patients – results from a large observational European study (SPACE)
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019

PP229 – Clinical profile of 116 patients undergoing post-COVID follow-up - A prospective study
Source: ERS Lung Science Conference 2021
Year: 2021

Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Preliminary results of a prospective cohort study on the risk of depression in patients with COPD in general practice
Source: Eur Respir J 2005; 26: Suppl. 49, 673s
Year: 2005

Late Breaking Abstract - 1-year radiological, functional and quality-of-life outcomes in patients with SARS-CoV-2 pneumonia: A prospective observational study.
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021



Preliminary results of the French national prospective cohort on IPF
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Psychiatric complications of COVID-19 pneumonia: preliminary results of a single-centre prospective study.
Source: Virtual Congress 2021 – COVID - 19
Year: 2021


Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008


Cross-sectional, observational study to estimate the prevalence of the eosinophilic phenotype for Brazilian patients with severe asthma: the BRAEOS study
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019
Year: 2020



The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008


General practice and office spirometry in asthma and COPD: preliminary data from the prospective, randomised, comparative ²SPACE² Italian study
Source: Eur Respir J 2004; 24: Suppl. 48, 87s
Year: 2004